Medical Devices. CZECH REPUBLIC PRK Partners s.r.o. advokátní kancelář
|
|
- Tamsyn Fisher
- 7 years ago
- Views:
Transcription
1 Medical Devices CZECH REPUBLIC PRK Partners s.r.o. advokátní kancelář CONTACT INFORMATION JUDr. Jan Kohout, partner Mgr. Monika Mašková, Life Sciences Coordinator PRK Partners s.r.o. advokátní kancelář Jáchymova 2, CZ PRAGUE 1 Tel.: jan.kohout@prkpartners.com monika.maskova@prkpartners.com 1. Definition of medical devices What is the definition of a medical device in your jurisdiction? In line with EU Directives a medical device means any instrument, apparatus, appliance, software, material or other article, whether used alone or in combination, including the necessary software for its proper application, intended by the manufacturer to be used for human beings for the purpose of - diagnosis, prevention, monitoring, treatment or alleviation of disease, - diagnosis, monitoring, treatment, alleviation of or compensation for an injury or handicap, - investigation, replacement or modification of the anatomy or of a physiological process, or - control of conception, and which does not achieve its principal intended action in or on the human body by pharmacological, immunological or metabolic means, but which may be assisted in its function by such means. In addition to the above definition, there are certain products specifically mentioned as being subject to the legal regime of medical devices. These include devices intended for administration of medical products, devices containing a medicinal product (including medicinal products made of human blood or plasma) which supplement the effect of the
2 device, in vitro medical devices, custom-made medical devices, medical devices intended for clinical investigation, active implantable medical devices and accessories to medical devices. 2. Combination products i. Which legal regime (on medicinal product or on medical devices) applies to combination products incorporating both medicinal products (drugs/biologics) and medical devices? The legal regime applicable to products incorporating both medicinal products (drugs/biologics) and medical devices depends on the main function of the product. If the main function of the combination product is pharmacological, immunological or metabolic, the product is subject to legal regime of medicinal products. However, if the main function is different (e.g. mechanical or electric), then the legal regime on medicinal devices applies. Specifically, combination products intended for one-time use are subject to the legal regime on medicinal products and, at the same time, legal regulations generally applicable to the technical requirements on products. ii. Are combination products (combining drugs and medical devices) subject to separate regulation in your jurisdiction? No. iii. If the answer to (i) is negative, what is the scope of application of the legal regimes: evaluating both the drug and device components of the combination product? Combination products regarded as medical devices (please see point i. above) are subject to the general legal regime governing the evaluation of medical devices. In addition, the legal regulation governing evaluation of drugs (mainly Act No. 378/2007 Coll., on Pharmaceutical Products, as amended) applies analogously to the evaluating of the drug component of the combination product. iv. What are the general conditions for review, approval and marketing the combination product? Generally, the conditions are the same as those for medical devices (for details please see Section 5 below). In addition, an expert statement regarding the safety and effectiveness of the drug component of the combination product must be issued by the competent authority, such as the European Medicines Agency ( EMEA ) or the State Institute for Drug Control ( SIDC ). 3. Borderline products Are there any official and binding criteria for determination whether the product is a medicinal product or medical device, or whether a product is a device requiring pre-review or a non-medical device? Yes. The key criteria for these differentiations derive from the legal definitions of medicinal products, medical devices and other types of products.
3 i. Are there any legal and binding criteria for determination whether the product is a medical device or medicinal product? Yes, the criteria derived from legal definitions of medicinal products and medical devices as well as certain other provisions of applicable laws and regulations are binding. Additional criteria that are non-binding can be found in incidental documents issued by competent regulatory authorities. ii. If the answer to (i) is positive, what are the main principles for differentiation? The key criteria for differentiation between medicinal products and medical devices are the product s main function and the main means of impact of the product. Supplementary non-binding criteria for differentiation between medicinal products and medical devices are listed in incidental documents and include the following: Proposed manner of use of the product including route of administration, recommended dosage and any restrictions on use, interaction, adverse effects, warnings, etc. Qualitative and quantitative composition of the product in relation to one unit of dose or pharmaceutical form, Proposed manner of use of the product including route of administration, Group of users, Proposed labelling and information for consumers, Information on matters relevant for the assessment of health risks associated with the product, Information on how the product is classified when placed on the market in other countries (classification in EU countries has priority). iii. Are there any significant court or administrative judgments demonstrating the rules of product differentiation? No. Moreover, the influence of past court decisions is limited in the Czech legal system as they are not generally binding and thus influence the decision making of courts of lower instance only by means of persuasiveness. Instead of publishing administrative decisions the SIDC and the Ministry of Health issue non-binding guidelines describing basic principles for product differentiation. In case of doubt it is possible to submit to the SIDC an official request to determine whether the product in question falls into the category of medicinal products or not. It is also possible to informally consult with the SIDC. iv. How is software that may have some related-medical applications regulated in your jurisdiction? Software which itself forms a separate medical device is regarded as an active medical device and subject to the legal regulation of active medical devices. Software which forms an accessory to a medical device is also subject to the legal regime of medical devices, and as such it is classified separately from the main medical device.
4 Software which is only a component and integral part of a medical device is subject to legal regulations applicable to the respective medical device. 4. Cellular or tissue based products Are there any official or binding criteria for determination whether a product is a animal or human based tissue or a medical device? Yes. The criteria for this differentiation derive from the legal definition of medical devices and certain other provisions of law governing medical devices. i. How are products composed of cells or animal/human tissue regulated in your jurisdiction? The handling of human cells and tissue is governed by a general legal framework (Act No. 296/2008 Coll., on Human Tissue and Cells, as amended). In addition, there are specialized categories of products containing human cells or tissue which are subject to different legal regimes. These are the legal regimes of medicinal products (Act No. 378/2007 Coll.), of transplantations (Act No. 285/2002 Coll.) and legal regime of medical devices (Act No. 123/2000 Coll.). The legal regime of medical devices also applies to medical devices containing animal tissue. ii. Are there any legal and binding criteria for determination whether the product is a medical device or cellular/tissue based product? Yes, the criteria derived from the legal definition of medicinal products as well as certain other provisions of the applicable laws and regulations are binding. iii. If the answer to (ii) is positive, what are the main principles for differentiation? The key differentiation principle is whether the product s main function complies with one or more of the functions listed in the definition of a medical device. iv. Are there any significant court or administrative judgments demonstrating the rules of product differentiation? No. Moreover, the influence of past court decisions is limited in the Czech legal system as they are not generally binding and thus influence the decision making of courts of lower instance only by means of persuasiveness. Instead of publishing administrative decisions, the SIDC and the Ministry of Health issue non binding guidelines describing basic principles for product differentiation. In case of doubt it is possible to submit an official request to the SIDC to determine whether the product in question falls into the category of medicinal products or not. It is also possible to informally consult with the SIDC.
5 5. Admission to trade of medical devices What are the requirements for admission (import) of medical devices into trade? The main generally applicable requirements are (i) assessment of conformity of the device with technical requirements set out by Act No. 22/1997 Coll., on Technical Requirements on Products, as amended, and review of suitability of the device for providing health care by means of clinical assessment, (ii) the CE mark must be affixed to the device (except for custom made devices and devices intended for clinical trials), (iii) issue of written declaration on conformity of the device and (iv) notification is sent to the Ministry of Health. i. Is clinical assessment required for admitting (importing) medical devices into trade? Yes, except for in vitro medical devices and in specific cases where assessment of conformity based on clinical data is not suitable in such instances the conformity assessment is done based on an assessment of its function, comparative testing and preclinical assessment. ii. If the answer to (i) is positive, are clinical trials required or is there an alternative basis for clinical assessment? Clinical assessment can be conducted without clinical trials provided that it is justified to rely on existing clinical data. iii. Is certification by an external certifying body required for compliance assessment of medical devices, or is a manufacturer s declaration of conformity sufficient? A manufacturer s declaration of conformity is sufficient for certain types of medical devices. iv. Is administrative pre-clearance or pre-approval of medical devices required for admission of medical devices into trade, or is post-launch notification sufficient? The manufacturer or its representative must notify to the Ministry of Health information relating to the certification of the medical device before the device is launched on the market. 6. Processing of personal data (privacy) What are the rules of processing of personal data in a number of activities performed by manufacturer/s distributors/ healthcare units with the use of medical devices. i. Are there any specific rules protecting the privacy of personal data of consumers purchasing medical devices, by manufacturer/distributors? No. The general legal regulation on data processing (Act No. 101/2000 Coll.) applies.
6 ii. Are there any specific rules of processing of personal data sourced by means of medical devices containing software, by healthcare units? Specific rules apply to the processing of personal data by healthcare units in connection with the provision health care (Act No. 20/1966 Coll.). However, there is no specific regulation applicable to personal data sourced by means of medical devices containing software. iii. Are there any specific rules of processing of personal data by manufacturers/distributors in case of collecting reports on medical incidents from customers? No. The general legal regulation on data processing (Act No. 101/2000 Coll.) applies. iv. What is the standard for reporting adverse events, and is reporting of events in foreign countries required, and using what standards? Adverse events must be reported using a prescribed form. The form and further details of the reporting are regulated by the Act on Medical Devices (Act No. 123/2000 Coll.) and a related regulation of the Ministry of Health (Regulation No. 501/2000 Coll.). Czech legal regulation requires only that the adverse event is reported to the responsible authority in the Czech Republic, i.e. the SIDC. The SIDC is responsible for transferring the information to authorities in other EU member states. 7. Reimbursement What is the optimal model of reimbursement of medical devices? Reimbursement of medical devices is currently being debated in the Czech Republic within the discussion on healthcare reform. Reimbursement based on a reference system which would provide reimbursement at an amount corresponding to that of other similar devices with comparable effects is among the most often discussed mechanisms. i. What are the rules of granting reimbursement of medical devices in your jurisdiction? Reimbursement of medical devices is regulated by the Act on Public Health Insurance (Act No. 48/1997 Coll.). Reimbursement generally applies to medical devices prescribed for the patient (i) to continue in the healing process, or (ii) to support stability of the patient s health situation, to distinctively improve the patient s health situation or to avoid its worsening, or (iii) to compensate or reduce the effects of a handicap including the replacement or modification of an anatomical structure or physiological process. The reimbursement amounts to 75% of the consumer price of the medical device. Reimbursement is provided for the basic and least expensive type of device in correlation to the extent and seriousness of the health handicap. 8. Distribution Is distribution and promotion of medical devices subject to legal regulation? Yes. In addition to general legal regulations on conducting business there are certain specific aspects of distribution of medical devices governed by the Act on Medical Devices (Act No. 123/2000 Coll.) and related legislation.
7 Promotion of medical devices is governed by the Act on Advertising (Act No. 40/1995 Coll.). i. Are there any specific regulations determining mode of business activity of medical devices distributors? The Act on Medical Devices (Act No. 123/2000 Coll.) sets out certain specific requirements, such as the obligation of the distributor to submit various notifications to the Ministry of Health and the SIDC. ii. Is administrative permit for medical devices distribution required? Distribution of medical devices requires a general trade license called Production, trade and services not included in Annexes 1 through 3 of the Act on Trades. In addition, the commencement of distribution of medical devices must be notified to the Ministry of Health. iii. Are there any specific limitations in distributing medical devices in your jurisdiction? The person who intends to place a medical device on the market in the Czech Republic in its own name is required to (i) have its seat or place of business in a member state of the European Union ( EU ) or (ii) appoint a single representative with a seat or place of business in an EU member state for all EU countries. In addition, there are various notification obligations connected with the distribution of medical devices. iv. Are obligations of distributors of medical devices specifically legally regulated? Yes, these obligations are set out in the Act on Medical Devices (Act No. 123/2000 Coll.) related legislation. v. What specific rules exist for advertising and promoting medical devices? Advertising and promoting medical devices is subject to the general legal on advertising (Act No. 40/1995 Coll.), without any specific rules. Specific rules apply only to presentations of medical devices for which a declaration on conformity was not issued. 9. Manufacturing How are manufacturing practices regulated? Manufacturing practices are regulated by secondary legislation implementing the Act on Medical Devices (Act No. 123/2000 Coll.). In addition, technical requirements are set out in technical norms developed and published by Czech Office for Standards, Metrology and Testing.
8 i. Are there any specific standards or regulations determining the quality of manufacturing practices? Yes. Governmental Regulation No. 336/2004 Coll., sets out requirements concerning design, construction and manufacturing of medical devices. In addition, criteria for overall quality management of medical devices production are set out in EN ISO13485:2003. ii. If the answer to (i) is positive, how are these good manufacturing practices or quality system regulations reviewed and enforced? Fulfillment of the respective requirements by the manufacturers is reviewed by authorized persons who issue certificates on compliance to the manufacturers. Compliance with applicable regulations is a part of the assessment of conformity for each type of medical device and a prerequisite for placing the device on the market. iii. Are establishments manufacturing medical devices, or components of medical devices, required to be registered with a government regulator? Yes. The manufacturer must submit the respective notification to the Ministry of Health. iv. Are these establishments inspected regularly by government regulators or authorized bodies, and what is the mode of such inspections? Yes. Inspections aimed at the manufacturing process are conducted by authorized persons established as non-governmental entities. The inspections include regular audits as well as inspections, which are not notified to the manufacturer in advance. 10. Regulatory Guidance How are the requirements communicated to medical device manufacturers? The requirements set out in legal regulations are published in the official Collection of Laws of the Czech Republic. Technical norms are published in the Bulletin of the Czech Office for Standards, Metrology and Testing. i. In what form do the laws and regulations appear that are applicable to medical device manufacturers? Legally binding regulations comprise laws, governmental regulations, notices and communications of the ministries. ii. Are informal guidance or the opinions of regulators available to device makers, and in what form? Yes. Informal guidelines are issued by regulators, mainly by the Ministry of Health and the SIDC. The guidelines are published in bulletins issued by the regulators, which are also posted on their web sites.
Medical Devices. AUSTRIA CHSH Cerha Hempel Spiegelfeld Hlawati
Medical Devices AUSTRIA CHSH Cerha Hempel Spiegelfeld Hlawati CONTACT INFORMATION Thomas Zivny Stefan Huber CHSH Cerha Hempel Spiegelfeld Hlawati Parkring 2, A-1010 Wien +43/1/51435-0 Thomas.zivny@chsh.com
More informationGUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES
Foreword GUIDANCE NOTES FOR MANUFACTURERS OF CLASS I MEDICAL DEVICES These guidance notes do not aim to be a definite interpretation of National Laws and/or regulations and are for guidance purpose only.
More informationMedical Devices. IRELAND Arthur Cox
Medical Devices IRELAND Arthur Cox CONTACT INFORMATION Colin Kavanagh Arthur Cox Earlsfort Centre Earlsfort Terrace Dublin 2, Ireland +353.1.618.0548 Colin.Kavanagh@arthurcox.com www.arthurcox.com 1. Definition
More informationHow To Know If A Mobile App Is A Medical Device
The Regulation of Medical Device Apps Prepared for West of England Academic Health Science Network and University of Bristol June 2014 June 2014 1 Table of Contents 1 Purpose...3 2 Scope...3 3 The Regulation
More informationSafeguarding public health The Regulation of Software as a Medical Device
Safeguarding public health The Regulation of Software as a Medical Device Dr Head of New and Emerging Technologies Medicines and Healthcare Products Regulatory Agency (MHRA) Crown Copyright 2013 About
More informationRegulatory Strategy for Drug-Device Combinations By John Worroll
THE MEDICAL DEVICE CONSULTING, AUDITING & TRAINING EXPERTS Regulatory Strategy for Drug-Device Combinations By John Worroll Introduction Drug-device combinations have always been a challenge to the regulatory
More informationMed-Info. Council Directive 93/42/EEC on Medical Devices. TÜV SÜD Product Service GmbH
Med-Info International expert information for the Medical Device industry Council Directive 93/42/E on Medical Devices Practice-oriented summary of the most important aspects and requirements contained
More informationGUIDANCE NOTE FOR MANUFACTURERS OF CUSTOM-MADE MEDICAL DEVICES
GUIDANCE NOTE FOR MANUFACTURERS OF CUSTOM-MADE MEDICAL DEVICES Foreword This guidance document is informative and advisory and has no legal authority. Individual national enforcement authorities are bound
More information2002 No. 618 CONSUMER PROTECTION. The Medical Devices Regulations 2002
STATUTORY INSTRUMENTS 2002 No. 618 CONSUMER PROTECTION The Medical Devices Regulations 2002 Made - - - - - 20th May 2002 Laid before Parliament 21st May 2002 Coming into force - - 13th June 2002 ARRANGEMENT
More informationGuide for Custom-Made Dental Device Manufacturers on Compliance with European Communities (Medical Devices) Regulations, 1994
Guide for Custom-Made Dental Device Manufacturers on Compliance with European Communities (Medical SUR-G0014-1 12 NOVEMBER 2013 This guide does not purport to be an interpretation of law and/or regulations
More informationAn introduction to the regulation of apps and wearables as medical devices
An introduction to the regulation of apps and wearables as medical devices Introduction Phones are increasingly equipped with a range of devices capable of being used as sensors, including gyroscopes,
More informationGuidance on the In Vitro Diagnostic Medical Devices Directive 98/79/EC
Guidance on the In Vitro Diagnostic Medical Devices Directive 98/79/EC August 2013 Contents 1 Introduction...3 2 Scope of the directive...3 2.1 What is an in vitro diagnostic medical device?... 3 2.2 Specimen
More informationCE Marking: Your Key to Entering the European Market
CE Marking: Your Key to Entering the European Market N. Gerard Zapiain U.S. Department of Commerce International Trade Administration Office of Microelectronics, Medical Equipment and Instrumentation I.
More informationMEDICAL DEVICES INTERIM REGULATION
Issued by the Saudi Food and Drug Authority Board of Directors decree number 1-8-1429 and dated 27 December 2008 The Interim was published in Umm Al-QURA Journal year 86 Issue No:4249 dated in 17 April
More information(OJ L 169, 12.7.1993, p. 1)
1993L0042 EN 11.10.2007 005.001 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents B COUNCIL DIRECTIVE 93/42/EEC of 14 June 1993 concerning
More informationThe Act on Medical Devices
The Act on Medical Devices The Act on Medical Devices of 2 nd August 1994 (Federal Law Gazette I, p. 1963), in the version of 7 th August 2002 (Federal Law Gazette I, p. 3146), last amended by Article
More informationUS & CANADA: REGULATION AND GUIDELINES ON MEDICAL SOFTWARE AND APPS OR
US & CANADA: REGULATION AND GUIDELINES ON MEDICAL SOFTWARE AND APPS OR A MEDICAL DEVICE IS A MEDICAL DEVICE IS A MEDICAL DEVICE AHWP Medical SW Workshop Taipei, Taiwan November 3, 2012 John G. Abbott,
More informationWHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE
WHITEPAPER: SOFTWARE APPS AS MEDICAL DEVICES THE REGULATORY LANDSCAPE White paper produced by Maetrics For more information, please contact global sales +1 610 458 9312 +1 877 623 8742 globalsales@maetrics.com
More informationEU Law and Life Sciences Mobile Health Apps. Webinar - Brussels, 9 July 2014
EU Law and Life Sciences Mobile Health Apps Webinar - Brussels, 9 July 2014 Dr. Dr. Adem Koyuncu, M.D. Partner Prof. Damien Geradin Partner Agenda Covington at a glance Mobile health apps - opportunities
More informationMedical Device Directive 2007/47/EC What is New? Are we moving towards Drug Rules?
Medical Device Directive 2007/47/EC What is New? Are we moving towards Drug Rules? CEMO Congress, Paris, February 3rd, 2011 Dr. Martine Dehlinger-Kremer Vice President Global Regulatory Affairs Agenda
More informationTRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP
DISCLAIMER: The EU reserves the right to make subsequent modifications to this text and to complement its proposals at a later stage, by modifying, supplementing or withdrawing all, or any part, at any
More informationGuidance Notes for Applicants of the Certificate for Clinical Trial on Medical Device
Guidance Notes for Applicants of the Certificate for Clinical Trial on Medical Device List of Contents Page 1. Introduction 1.1 The Medical Device Administrative Control System and the 3 proposed legislation
More informationGuidelines for conformity assessment of In Vitro Fertilisation (IVF) and Assisted Reproduction Technologies (ART) products
EUROPEAN COMMISSION DG HEALTH & CONSUMERS Directorate B - Consumer Affairs Unit B2 Health Technology and Cosmetics MEDICAL DEVICES: Guidance document MEDDEV 2.2/4 January 2012 Guidelines for conformity
More informationThe Regulation of Medical Devices in the UK
The Regulation of Medical Devices in the UK 1. What are the main requirements for a medical device to enter into the market and how are they regulated? Are there any licensing, marketing authorisation,
More informationRegulation and Risk Management of Combination Products
Regulation and Risk Management of Combination Products Katherine Ulman Associate Scientist Global Regulatory Compliance Manager Dow Corning Healthcare Jim Curtis Senior Specialist, Healthcare Applications
More informationGUIDELINES ON MEDICAL DEVICES. IVD GUIDANCES : Borderline issues A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single Market : regulatory environment, standardisation and New Approach Pressure equipment, medical devices, metrology MEDDEV. 2.14/1 rev. 1 January
More informationFinal Document. Software as a Medical Device (SaMD): Key Definitions. Date: 9 December 2013. Despina Spanou, IMDRF Chair. IMDRF/SaMD WG/N10FINAL:2013
Final Document Title: Authoring Group: Software as a Medical Device (SaMD): Key Definitions IMDRF SaMD Working Group Date: 9 December 2013 Despina Spanou, IMDRF Chair This document was produced by the
More informationNational Decontamination Guidance on Loan Medical Devices (Reusable): Roles & Responsibilities GUID 5002
National Decontamination Guidance on Loan Medical Devices (Reusable): Roles & Responsibilities GUID 5002 July 2015 Contents Page 1.0 Executive summary... 3 2.0 Background... 4 3.0 Objective... 5 4.0 Scope...
More informationImporting pharmaceutical products to China
Importing pharmaceutical products to China Imported pharmaceutical products need pre-market approval before entering the Chinese market Imported drugs for human use are required to obtain pre-market approval
More informationGUIDELINES FOR IMPORT AND MANUFACTURE OF MEDICAL DEVICES
GUIDELINES FOR IMPORT AND MANUFACTURE OF MEDICAL DEVICES The Ministry of Health and F.W. under Gazette notification S.O. 1468 (E) dated 6/10/2005 declared the following sterile devices to be considered
More informationManual for ITC's clients, 2013. Conformity assessment of ACTIVE IMPLANTABLE MEDICAL DEVICES pursuant to Council Directive 90/385/EEC
Manual for ITC's clients, 2013 Conformity assessment of ACTIVE IMPLANTABLE MEDICAL DEVICES pursuant to Council Directive 90/385/EEC Institute for Testing and Certification, inc., Czech Republic, EU 1.
More informationWe ask that you allow our office 24-48 hours to respond to telephone messages and callbacks.
NOTICE OF PRIVACY PRACTICE Associated Physicians Group This notice describes how your medical information may be disclosed and how you can get access to this information. Please review these policies carefully.
More informationHow to apply for Medical Device License in Taiwan
How to apply for Medical Device License in Taiwan According to Pharmaceutical Affairs Act (PAA), all medical devices regardless their classification shall apply for Medical Device License before they are
More informationMedical Software Development. International standards requirements and practice
Medical Software Development International standards requirements and practice Food and Drug Administration What? A public health agency Why? Protect American consumers How? By enforcing the Federal Food,
More informationGOVERNMENT OF THE RUSSIAN FEDERATION RESOLUTION from December 27, 2012 N 1416 APPROVAL OF THE RULES STATE REGISTRATION OF MEDICAL PRODUCTS
GOVERNMENT OF THE RUSSIAN FEDERATION RESOLUTION from December 27, 2012 N 1416 APPROVAL OF THE RULES STATE REGISTRATION OF MEDICAL PRODUCTS In accordance with Article 38 of the Federal Law "On the basis
More informationSarah Chandler A/Head, Regulatory and Scientific Section Medical Devices Bureau sarah.chandler@hc-sc.gc.ca
Software Regulated as a Medical Device Sarah Chandler A/Head, Regulatory and Scientific Section Medical Devices Bureau sarah.chandler@hc-sc.gc.ca Therapeutic Products Directorate Director General S. Sharma
More informationCombination Products Regulation in the United States
Combination Products Regulation in the United States Presenter: Scott Sardeson RAC US/EU 3M Health Care St. Paul, MN USA 1 Presentation Outline Combination products Definitions and Regulations Jurisdiction
More informationThe Medical Device Industry in Korea: Strategies for Market Entry
The Industry in Korea: Strategies Seth J. Goldenberg, Senior Principal Scientist, NAMSA; Yongha Na, Director, Medipert Regulatory NAMSA Whitepaper #09 06/2014 Seth J. Goldenberg, PhD (sgoldenberg@namsa.com)
More informationReporting Changes to your Notified Body
Reporting Changes to your Notified Body Vicky Medley - Head of QMS, Medical Devices September 2015 1) Requirements & Guidance 2) Reporting Changes - What, When, Why & How 3) Some examples 4) Summary &
More informationMedical Devices: CE Marking Step-by Step
Medical Devices: CE Marking Step-by Step Sylvia Mohr Standards Specialist U.S. Mission to the European Union 1 Introduction CE marking in 8 Steps Overview intended purpose - technical documentation classification
More informationCorrespondence between ISO 13485:2003 and the US Quality System Regulation
Correspondence between ISO 13485:2003 and the US Quality System Regulation Correspondence between ISO 13485:2003 and the US Quality System Regulation 1 Scope 1.1 General This International Standard specifies
More informationEXCHANGE RULES, SECTION XII. Conditions for Admission of Collective Investment Securities to Trading on the Regulated Market of the Exchange
EXCHANGE RULES, SECTION XII. Conditions for Admission of Collective Investment Securities to Trading on the Regulated Market of the Exchange PART I. GENERAL Article 1 Subject Matter and Definitions (1)
More informationICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals. Step 5
European Medicines Agency July 1996 CPMP/ICH/140/95 ICH Topic S 1 A The Need for Carcinogenicity Studies of Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON THE NEED FOR CARCINOGENICITY STUDIES OF PHARMACEUTICALS
More informationRADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES
RADIOPHARMACEUTICALS BASED ON MONOCLONAL ANTIBODIES Guideline Title Radiopharmaceuticals based on Monoclonal Antibodies Legislative basis Directives 65/65/EEC, 75/318/EEC as amended, Directive 89/343/EEC
More informationJEFFERSON CARDIOLOGY NOTICE OF HEALTH INFORMATION PRACTICES
JEFFERSON CARDIOLOGY NOTICE OF HEALTH INFORMATION PRACTICES This notice describes how medical information about you may be used and disclosed and how you can get access to this information. Please review
More informationWant to know more about the Notified Body?
NBG/V 2/07/14 BSI Notified Body (0086) Kitemark Court Davy Avenue Knowlhill Milton Keynes MK5 8PP United Kingdom T: +44 845 080 9000 E: eu.medicaldevices@bsigroup.com W: medicaldevices.bsigroup.com Want
More informationStandard Operating Procedure. Clinical Trial Authorisation
Standard Operating Procedure for Clinical Trial Authorization Scope This SOP has been written to describe the procedure undertaken to apply for Clinical Trial Authorisation from Competent Authorities in
More informationGUIDELINES ON MEDICAL DEVICES EVALUATION OF CLINICAL DATA : A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES
EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single Market : regulatory environment, standardisation and New Approach Pressure equipment, medical devices, metrology MEDDEV. 2.7.1 April 2003 GUIDELINES
More informationSoftware within the medical device regulatory framework in the EU
Software within the medical device regulatory framework in the EU E-HEALTH WEEK (AMSTERDAM, 10 JUNE 2016) Erik Hansson, Deputy Head of Unit, DG GROWTH - Health Technology and Cosmetics, European Commission
More informationMobile Medical Application Development: FDA Regulation
Mobile Medical Application Development: FDA Regulation Mobile Medical Applications: Current Environment Currently over 100,000 mobile health related applications are available for download; there is an
More informationBRITISH DERMATOLOGICAL NURSING GROUP
Nurse Led systemic monitoring clinics guidance on setting up this service Introduction Nurse led systemic monitoring clinics are an innovative approach to improving care delivery and maintaining both a
More informationTHE CZECH MARKET WITH IN VITRO DIAGNOSTIC MEDICAL DEVICES
THE CZECH MARKET WITH IN VITRO DIAGNOSTIC MEDICAL DEVICES 1 Motto: Finances used in relation to IVD are not costs but true investments in health. Czech Association of In Vitro Diagnostic Medical Suppliers
More informationEnd of consultation (deadline for comments) 14 October 2009. Adoption by Committee for advanced therapies 15 October 2010
15 October 2010 EMA/CAT/418458/2008/corr. Committee for advanced therapies (CAT) Procedural advice on the certification of quality and nonclinical data for small and medium sized enterprises developing
More informationIntroduction Processes and KPIs Health Care Value Chain. Rafael Provencio
Introduction Processes and KPIs Health Care Value Chain Rafael Provencio Table of contents 1. Regulatory Framework EU 2. Hospital Value Chain 3. Processes 4. KPIs 2 What is the goal of the regulatory framework?
More informationLegal compliance for developers. Training materials (prepared by Tilburg University)
Legal compliance for developers using FI-STAR ehealth platform Training materials (prepared by Tilburg University) Target audience: Target audience and objectives developers & other potential users of
More informationREGULATIONS FOR THE DEGREE OF BACHELOR OF PHARMACY IN CHINESE MEDICINE [PART-TIME] (BPharm[ChinMed])
REGULATIONS FOR THE DEGREE OF BACHELOR OF PHARMACY IN CHINESE MEDICINE [PART-TIME] (BPharm[ChinMed]) These regulations apply to students admitted to the first year of study in and after the academic year
More informationAUSTRALIAN REGULATORY GUIDELINES FOR MEDICAL DEVICES
AUSTRALIAN REGULATORY GUIDELINES FOR MEDICAL DEVICES Version 1.0 April 2010 Version history Version Description of change Author Effective Date 1.0 Initial publication on TGA website ODBT 28 April 2010
More informationPHV- 4 version 1 ELECTRONIC ADVERSE DRUG REACTION REPORTING
PHV- 4 version 1 ELECTRONIC ADVERSE DRUG REACTION REPORTING This guideline supersedes guideline PHV 4 as of September 16 2008. 1. Introduction and general provisions 1.1 Purpose of the guideline The guideline
More informationNavigating the New EU Rules for Medical Device Software
Navigating the New EU Rules for Medical Device Software Mathias Klümper and Erik Vollebregt examine how European Directive 2007/47/EC will affect requirements for medical device software. Directive 2007/47/EC
More informationMedical Device Software Do You Understand How Software is Regulated?
Medical Device Software Do You Understand How Software is Regulated? By Gregory Martin Agenda Relevant directives, standards, and guidance documents recommended to develop, maintain, and validate medical
More informationTHIS NOTICE DESCRIBES HOW HEALTH INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION.
UNIVERSITY OF SOUTHERN CALIFORNIA USC NETWORK MEDICAL PLAN, DELTA DENTAL PLAN, USC SENIOR CARE PLAN AND HEALTHCARE FLEXIBLE SPENDING ACCOUNT PLAN NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW HEALTH
More informationNOTICE OF PRIVACY PRACTICES FOR ONSLOW AMBULATORY SERVICES, INC.
NOTICE OF PRIVACY PRACTICES FOR ONSLOW AMBULATORY SERVICES, INC. THIS NOTICE DESCRIBES HOW MEDIAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE
More informationEmerging Device Topics for Regulatory Consideration.. Janine Jamieson May 2015
Emerging Device Topics for Regulatory Consideration. Janine Jamieson May 2015 Disclaimer These are my personal views and not necessarily those of MHRA as an organisation. 2 European regulation of combination
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S1A. Current Step 4 version
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE GUIDELINE ON THE NEED FOR CARCINOGENICITY STUDIES
More informationMedical/Clinical Assistant CIP 51.0801 Task Grid
1 Secondary Task List 100 PHARMACOLOGY 101 Measure drug dosages using droppers, medicine cups, syringes, and other specialized devices. 102 Utilize correct technique to administer medications using the
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL VERSION 4.1
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, SANCO/D/6/SF/mg/ddg1.d.6(2013) IMPORTATION OF ACTIVE SUBSTANCES
More informationRiver Valley Therapy & Sports Medicine, Inc. Notice of Privacy Practices
River Valley Therapy & Sports Medicine, Inc. Notice of Privacy Practices This notice describes how medical information about you may be used and disclosed and how you can get access to this information.
More informationDECISIONS ADOPTED JOINTLY BY THE EUROPEAN PARLIAMENT AND THE COUNCIL
L 218/82 EN Official Journal of the European Union 13.8.2008 DECISIONS ADOPTED JOINTLY BY THE EUROPEAN PARLIAMENT AND THE COUNCIL DECISION No 768/2008/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of
More informationCTC Technology Readiness Levels
CTC Technology Readiness Levels Readiness: Software Development (Adapted from CECOM s Software Technology Readiness Levels) Level 1: Basic principles observed and reported. Lowest level of software readiness.
More informationDIRECTIVE 2014/32/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
29.3.2014 Official Journal of the European Union L 96/149 DIRECTIVE 2014/32/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 26 February 2014 on the harmonisation of the laws of the Member States relating
More informationUnit/Standard Number. Proficiency Level Achieved: (X) Indicates Competency Achieved to Industry Proficiency Level
1 Secondary Task List 100 INTRODUCTION TO HEALTHCARE 101 Identify the roles and educational/credentialing requirements of various health care practitioners. 102 Describe the 's job description, personal
More informationDoes the Regulation Apply?
A. JURISDICTION OF UNITED KINGDOM COURTS (see articles 3 and 2(d)) Does the Regulation Apply? If the proceedings are based on the debtor s insolvency, the debtor is not excluded under article 1(2) and
More informationEPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical Devices
EPF Position Statement on the European Commission s proposal for a Regulation on In Vitro Medical 03/09/2013 In Vitro Diagnostic medical devices include all tests performed to provide a diagnosis by assessing
More informationPRIVACY POLICY (IN ACCORDANCE WITH HIPAA)
PRIVACY POLICY (IN ACCORDANCE WITH HIPAA) The privacy of your medical information is important to us. We understand that your medical information is personal and we are committed to protecting it. This
More informationFood supplements. Summary information on legislation relating to the sale of food supplements
Food supplements Summary information on legislation relating to the sale of food supplements 1 This guidance applies to the whole of the UK and was prepared by the Department of Health in association with
More informationWhat is a medical device? Medical Devices: Roadmap to Market. Kathryn Klaus, Esq.
Medical Devices: Roadmap to Market Kathryn Klaus, Esq. The last installment of Regulatory 360 discussed the FDA organization in general where it came from and a broad overview of how it operates, as well
More informationct A Insolvency Act Insolvency ISBN 978-80-7357-681-3
Insolvency Act Insolvency Act Insolvency Act Example of quotation: Insolvency Act. Prague : Wolters Kluwer ČR, a. s., 2011, p. 216. Legal state of the publication as of 31 th August 2011. Updated version
More informationGlossary of terms used in our standards. June 2010. Upholding standards and public trust in pharmacy www.pharmacyregulation.org
Glossary of terms used in our standards June 2010 About us The General Pharmaceutical Council is the regulator for pharmacists, pharmacy technicians and registered pharmacy premises in England, Scotland
More informationACT. Of.2014. On Cyber Security and Change of Related Acts (Act on Cyber Security)
ACT Of.2014 On Cyber Security and Change of Related Acts (Act on Cyber Security) The Parliament has resolved on the following Act of the Czech Republic: PART ONE Cyber Security Chapter I General provisions
More informationHaving regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof;
DIRECTIVE 65/65/EEC Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products (OJ L No 22 of
More informationRESEARCH INVOLVING HUMAN SUBJECTS
RESEARCH INVOLVING HUMAN SUBJECTS GUIDELINES FOR IRBS PART A: INTRODUCTION AND CURRENT FRAMEWORK SECTION I: INTRODUCTION 1. Introduction About these Guidelines 1.1. The Bioethics Advisory Committee (BAC)
More informationPresented by Rosemarie Bell 24 April 2014
Global Good Manufacturing Practice A Comparability Study to Link Good Manufacturing Practice Standards for World Wide Compliance Within the Cellular Therapy Industry Presented by Rosemarie Bell 24 April
More informationCDRH Regulated Software
CDRH Regulated Software An Introduction John F. Murray Jr. CDRH Software Compliance Expert CDRH Regulates Software in the following areas Medical Devices Automation of Production Systems Automation of
More informationInsurance and compensation in the event of injury in Phase I clinical trials
Insurance and compensation in the event of injury in Phase I clinical trials Guidance developed by the Association for the British Pharmaceutical Industry, the BioIndustry Association and the Clinical
More informationMedical Devices. Notified Bodies and the CE certification Process for Medical Devices. European Surgical Robotics Demonstration Day
Medical Devices Notified Bodies and the CE certification Process for Medical Devices European Surgical Robotics Demonstration Day 27 th March 2014, Leuven, Belgium 1 Bart Mersseman Product Manager Medical
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health products and systems Medicinal products quality, safety and efficacy Brussels, 15 May 2013 sanco.ddg1.d.6(2013)1154216 THE RULES GOVERNING
More informationEU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE
EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE Purpose 1. The Clinical Trials Directive 2001/20/EC heralds certain additional responsibilities for the Medicines and Healthcare
More informationThe New Paradigm for Medical Device Safety. Addressing the Requirements of IEC 60601-1 Edition 3.1
The New Paradigm for Medical Device Safety Addressing the Requirements of IEC 60601-1 Edition 3.1 Medical devices play a vital role in the diagnosis and treatment of most health-related conditions, and
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY VERSION 7
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Health systems and products Medicinal products quality, safety and efficacy Brussels, IMPORTATION OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS
More informationTemplate for essential information to be provided for proposals including clinical trials / studies / investigations
Template for essential information to be provided for proposals including clinical trials / studies / investigations Document history Version 2016callsV1 September 2015 Modifications (compared to previous
More informationAGREEMENT On the Uniform Principles and Rules Governing Market Circulation of Medical Devices within the Eurasian Economic Union
AGREEMENT On the Uniform Principles and Rules Governing Market Circulation of Medical Devices within the Eurasian Economic Union The Member States of the Eurasian Economic Union, hereinafter referred to
More informationJOINT NOTICE OF OUR HEALTH INFORMATION PRACTICES
JOINT NOTICE OF OUR HEALTH INFORMATION PRACTICES THIS NOTICE DESCRIBES HOW INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY. Jennings
More informationGuidelines for preparing Standard Operating Procedures (SOP) for Institutional Ethics Committee for Human Research
Guidelines for preparing Standard Operating Procedures (SOP) for Institutional Ethics Committee for Human Research 1. Objective: The objective of this SOP is to contribute to the effective functioning
More informationDr. Adam Apfelblat 5140 Highland Road Waterford 48327 Phone: (248)618-3467 Fax: (248)618-3515
Dr. Adam Apfelblat 5140 Highland Road Waterford 48327 HIPAA NOTICE OF PRIVACY PRACTICES PLEASE REVIEW THIS NOTICE CAREFULLY. IT DESCRIBES HOW YOUR MEDICAL INFORMATION MAY BE USED AND DISCLOSED AND HOW
More informationHIPAA PRIVACY NOTICE PLEASE REVIEW IT CAREFULLY
HIPAA PRIVACY NOTICE THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN OBTAIN ACCESS TO THIS INFORMATION. INTRODUCTION PLEASE REVIEW IT CAREFULLY Moriarty
More information2 Human medicines: scope of regulation
2 Human medicines: scope of regulation Karen Pitchford Consolidation of Medicines Legislation (2012) Until August 2012, UK medicines legislation comprised the Medicines Act 1968 (the 1968 Act), around
More informationResponse of the German Medical Association
Response of the German Medical Association to the European Commission proposal for a regulation of the European Parliament and of the Council on clinical trials on medicinal products for human use, and
More informationADVANCED INTEGRATIVE REHABILITATION AND PAIN CENTER David P. Sniezek, DC, MD, MBA, FAAIM NOTICE OF PRIVACY PRACTICES
ADVANCED INTEGRATIVE REHABILITATION AND PAIN CENTER David P. Sniezek, DC, MD, MBA, FAAIM NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND
More informationSASKATCHEWAN COLLEGE OF PHARMACISTS Electronic Transmission of Prescriptions. Policy Statement and Guidelines for Pharmacists
SASKATCHEWAN COLLEGE OF PHARMACISTS Electronic Transmission of Prescriptions PREAMBLE This document replaces the Operational Guidelines - Facsimile Transmission of Prescriptions Current legislation allows
More informationB I L L. No. 183 An Act to amend The Saskatchewan Employment Act and The Saskatchewan Employment Amendment Act, 2014
B I L L No. 183 An Act to amend The Saskatchewan Employment Act and The Saskatchewan Employment Amendment Act, 2014 (Assented to ) HER MAJESTY, by and with the advice and consent of the Legislative Assembly
More information